SG10202103545PA - Early post-transfection isolation of cells (epic) for biologics production - Google Patents
Early post-transfection isolation of cells (epic) for biologics productionInfo
- Publication number
- SG10202103545PA SG10202103545PA SG10202103545PA SG10202103545PA SG10202103545PA SG 10202103545P A SG10202103545P A SG 10202103545PA SG 10202103545P A SG10202103545P A SG 10202103545PA SG 10202103545P A SG10202103545P A SG 10202103545PA SG 10202103545P A SG10202103545P A SG 10202103545PA
- Authority
- SG
- Singapore
- Prior art keywords
- epic
- cells
- early post
- biologics production
- transfection isolation
- Prior art date
Links
- 229960000074 biopharmaceutical Drugs 0.000 title 1
- 238000002955 isolation Methods 0.000 title 1
- 238000004519 manufacturing process Methods 0.000 title 1
- 238000001890 transfection Methods 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P21/00—Preparation of peptides or proteins
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/43504—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/70592—CD52
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/70596—Molecules with a "CD"-designation not provided for elsewhere
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/0081—Purging biological preparations of unwanted cells
- C12N5/0087—Purging against subsets of blood cells, e.g. purging alloreactive T cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/10—Cells modified by introduction of foreign genetic material
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N15/00—Investigating characteristics of particles; Investigating permeability, pore-volume or surface-area of porous materials
- G01N15/10—Investigating individual particles
- G01N15/14—Optical investigation techniques, e.g. flow cytometry
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N15/00—Investigating characteristics of particles; Investigating permeability, pore-volume or surface-area of porous materials
- G01N15/10—Investigating individual particles
- G01N15/14—Optical investigation techniques, e.g. flow cytometry
- G01N15/149—Optical investigation techniques, e.g. flow cytometry specially adapted for sorting particles, e.g. by their size or optical properties
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- General Engineering & Computer Science (AREA)
- Biophysics (AREA)
- Microbiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicinal Chemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Toxicology (AREA)
- Cell Biology (AREA)
- Immunology (AREA)
- Physics & Mathematics (AREA)
- Plant Pathology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Dispersion Chemistry (AREA)
- Analytical Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Hematology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Epoxy Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201662405392P | 2016-10-07 | 2016-10-07 |
Publications (1)
Publication Number | Publication Date |
---|---|
SG10202103545PA true SG10202103545PA (en) | 2021-05-28 |
Family
ID=60302441
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG10202103545PA SG10202103545PA (en) | 2016-10-07 | 2017-10-06 | Early post-transfection isolation of cells (epic) for biologics production |
SG11201903018WA SG11201903018WA (en) | 2016-10-07 | 2017-10-06 | Early post-transfection isolation of cells (epic) for biologics production |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG11201903018WA SG11201903018WA (en) | 2016-10-07 | 2017-10-06 | Early post-transfection isolation of cells (epic) for biologics production |
Country Status (9)
Country | Link |
---|---|
US (3) | US20180119192A1 (en) |
EP (1) | EP3523440A1 (en) |
CN (1) | CN110050065B (en) |
AU (2) | AU2017341028B2 (en) |
CA (1) | CA3039598A1 (en) |
MX (1) | MX2019004013A (en) |
SG (2) | SG10202103545PA (en) |
TW (2) | TWI795373B (en) |
WO (1) | WO2018067964A1 (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IL309289A (en) | 2015-10-09 | 2024-02-01 | Genzyme Corp | Improved flare (flow cytometry attenuated reporter expression) technology for rapid bulk sorting |
US20180119192A1 (en) | 2016-10-07 | 2018-05-03 | Genzyme Corporation | Early post-transfection isolation of cells (epic) for biologics production |
Family Cites Families (43)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4818700A (en) | 1985-10-25 | 1989-04-04 | Phillips Petroleum Company | Pichia pastoris argininosuccinate lyase gene and uses thereof |
US4812405A (en) | 1986-02-18 | 1989-03-14 | Phillips Petroleum Company | Double auxotrophic mutants of Pichia pastoris and methods for preparation |
US4937190A (en) | 1987-10-15 | 1990-06-26 | Wisconsin Alumni Research Foundation | Translation enhancer |
US4929555A (en) | 1987-10-19 | 1990-05-29 | Phillips Petroleum Company | Pichia transformation |
CA2063799A1 (en) | 1989-07-24 | 1991-01-25 | Frank S. Genbauffe | Prevention of internal initiation |
US5648267A (en) | 1992-11-13 | 1997-07-15 | Idec Pharmaceuticals Corporation | Impaired dominant selectable marker sequence and intronic insertion strategies for enhancement of expression of gene product and expression vector systems comprising same |
WO1994026087A2 (en) | 1993-05-14 | 1994-11-24 | Connor Kim C O | Recombinant protein production and insect cell culture and process |
US5429746A (en) | 1994-02-22 | 1995-07-04 | Smith Kline Beecham Corporation | Antibody purification |
US7252989B1 (en) | 1994-04-04 | 2007-08-07 | Board Of Regents, The University Of Texas System | Adenovirus supervector system |
US5955349A (en) | 1996-08-26 | 1999-09-21 | Zymogenetics, Inc. | Compositions and methods for producing heterologous polypeptides in Pichia methanolica |
US5736383A (en) | 1996-08-26 | 1998-04-07 | Zymogenetics, Inc. | Preparation of Pichia methanolica auxotrophic mutants |
WO1998037189A1 (en) | 1997-02-25 | 1998-08-27 | Qbi Enterprises Ltd. | Ires sequences with high translational efficiency and expression vectors containing the sequence |
US7001733B1 (en) | 1998-05-12 | 2006-02-21 | Rigel Pharmaceuticals, Inc. | Methods and compositions for screening for modulations of IgE synthesis, secretion and switch rearrangement |
US6258559B1 (en) | 1999-03-22 | 2001-07-10 | Zymogenetics, Inc. | Method for producing proteins in transformed Pichia |
ES2257303T3 (en) | 1999-07-12 | 2006-08-01 | Genentech, Inc. | VECTORS OF EXPRESSION AND PROCEDURES. |
US20050005310A1 (en) | 1999-07-12 | 2005-01-06 | Genentech, Inc. | Expression vectors and methods |
US20020058243A1 (en) | 2000-02-02 | 2002-05-16 | Kurt Jarnigan | Rapid, parallel identification of cell lines |
WO2002070710A1 (en) | 2001-03-01 | 2002-09-12 | University Of California | Method to identify ires elements |
DE10143237A1 (en) | 2001-09-04 | 2003-03-20 | Icon Genetics Ag | Manufacture of artificial internal ribosomal entry point elements (Ires elements) |
DE10143238A1 (en) | 2001-09-04 | 2003-03-20 | Icon Genetics Ag | Identification of eukaryotic internal ribosome entry sites (IRES) elements |
CN1668634A (en) | 2002-05-22 | 2005-09-14 | 比奥根艾迪克Ma公司 | Detection of secreted polypeptides |
US7119187B2 (en) | 2002-07-09 | 2006-10-10 | National Health Research Institutes | Internal ribosome entry site of the labial gene for protein expression |
GB0216648D0 (en) | 2002-07-18 | 2002-08-28 | Lonza Biologics Plc | Method of expressing recombinant protein in CHO cells |
AU2003252111A1 (en) | 2002-07-19 | 2004-02-09 | Diversa Corporation | Fluorescent proteins, nucleic acids encoding them and methods for making and using them |
US7384744B2 (en) | 2002-11-29 | 2008-06-10 | Boehringer Ingelheim Pharma Gmbh & Co., Kg | Expression vector, methods for the production of heterologous gene products and for the selection of recombinant cells producing high levels of such products |
US7344886B2 (en) * | 2002-11-29 | 2008-03-18 | Boehringer Ingelheim Pharma Gmbh & Co., Kg | Neomycin-phosphotransferase-genes and methods for the selection of recombinant cells producing high levels of a desired gene product |
US20060173168A1 (en) | 2002-12-16 | 2006-08-03 | Wayne State University | Bioactive peptides and unique ires elements from myelin proteolipid protein plp/dm20 |
DK2332972T3 (en) | 2003-06-24 | 2018-04-23 | Genzyme Corp | Hitherto UNKNOWN BETA-ACTIN AND RPS21 PROMOTORS AND APPLICATIONS |
US7776584B2 (en) | 2003-08-01 | 2010-08-17 | Genetix Limited | Animal cell colony picking apparatus and method |
US20070178072A1 (en) | 2004-03-31 | 2007-08-02 | Kirin Beer Kabushiki Kaisha | Method for inducing differentiation of regulatory t cells usinggip-anchored protein agonist and pharmaceutical composition therefor ( as amended |
US7078179B2 (en) | 2004-05-04 | 2006-07-18 | Newlink Genetics Corporation | Selectable gene marker system based on expression of N-acetyllactosaminide 3-α galactosyltransferase |
SI1809750T1 (en) | 2004-11-08 | 2012-08-31 | Chromagenics Bv | Selection of host cells expressing protein at high levels |
MX2007004595A (en) | 2004-11-08 | 2007-08-15 | Chromagenics Bv | Selection of host cells expressing protein at high levels. |
CA2588936A1 (en) * | 2004-12-14 | 2006-06-22 | F. Hoffmann-La Roche Ag | Method for improved selection of rnai transfectants |
KR101087809B1 (en) * | 2006-04-10 | 2011-11-29 | 더 리젠츠 오브 더 유니버시티 오브 캘리포니아 | Systems for collection of single cells and colonies |
PT2064337E (en) | 2006-09-20 | 2012-07-26 | Genzyme Corp | A facs-and reporter protein-based system for high throughput development of therapeutic proteins |
EP2644199B1 (en) | 2007-03-05 | 2017-10-11 | NewSouth Innovations Pty Limited | Methods for detecting and modulating the sensitivity of tumour cells to anti-mitotic agents |
WO2010147464A1 (en) * | 2009-06-15 | 2010-12-23 | Cellagenics B.V. | Use of a cysteine synthesizing enzyme as selectable marker |
EP2588862A2 (en) | 2010-07-01 | 2013-05-08 | Glaxo Group Limited | Improved method for selecting high producing cell lines |
DE18200782T1 (en) | 2012-04-02 | 2021-10-21 | Modernatx, Inc. | MODIFIED POLYNUCLEOTIDES FOR THE PRODUCTION OF PROTEINS ASSOCIATED WITH DISEASES IN HUMANS |
WO2014141037A1 (en) | 2013-03-11 | 2014-09-18 | Novartis Ag | Method of screening cell clones |
IL309289A (en) | 2015-10-09 | 2024-02-01 | Genzyme Corp | Improved flare (flow cytometry attenuated reporter expression) technology for rapid bulk sorting |
US20180119192A1 (en) | 2016-10-07 | 2018-05-03 | Genzyme Corporation | Early post-transfection isolation of cells (epic) for biologics production |
-
2017
- 2017-10-06 US US15/727,272 patent/US20180119192A1/en not_active Abandoned
- 2017-10-06 SG SG10202103545PA patent/SG10202103545PA/en unknown
- 2017-10-06 AU AU2017341028A patent/AU2017341028B2/en active Active
- 2017-10-06 CA CA3039598A patent/CA3039598A1/en active Pending
- 2017-10-06 SG SG11201903018WA patent/SG11201903018WA/en unknown
- 2017-10-06 WO PCT/US2017/055583 patent/WO2018067964A1/en unknown
- 2017-10-06 TW TW106134586A patent/TWI795373B/en active
- 2017-10-06 TW TW112104729A patent/TW202346598A/en unknown
- 2017-10-06 MX MX2019004013A patent/MX2019004013A/en unknown
- 2017-10-06 EP EP17797462.3A patent/EP3523440A1/en active Pending
- 2017-10-06 CN CN201780075590.6A patent/CN110050065B/en active Active
-
2019
- 2019-11-14 US US16/683,837 patent/US11685943B2/en active Active
-
2023
- 2023-05-10 US US18/315,332 patent/US20240026410A1/en active Pending
-
2024
- 2024-03-21 AU AU2024201853A patent/AU2024201853A1/en active Pending
Also Published As
Publication number | Publication date |
---|---|
AU2017341028A1 (en) | 2019-05-23 |
TW201827598A (en) | 2018-08-01 |
US20240026410A1 (en) | 2024-01-25 |
TWI795373B (en) | 2023-03-11 |
EP3523440A1 (en) | 2019-08-14 |
AU2017341028B2 (en) | 2023-12-21 |
AU2024201853A1 (en) | 2024-04-11 |
CN110050065B (en) | 2024-05-07 |
US20200299743A1 (en) | 2020-09-24 |
CN110050065A (en) | 2019-07-23 |
CA3039598A1 (en) | 2018-04-12 |
WO2018067964A1 (en) | 2018-04-12 |
MX2019004013A (en) | 2019-08-14 |
US20180119192A1 (en) | 2018-05-03 |
TW202346598A (en) | 2023-12-01 |
SG11201903018WA (en) | 2019-05-30 |
US11685943B2 (en) | 2023-06-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL258538A (en) | Early post-transfection isolation of cells (epic) for biologics production | |
EP3368474A4 (en) | Electrochemical process for gas separation | |
EP3345990A4 (en) | Pluripotent stem cell production system | |
EP3177904A4 (en) | Platelet-targeted microfluidic isolation of cells | |
EP3041080A4 (en) | Secondary cell using hydroxide-ion-conductive ceramic separator | |
HK1252635A1 (en) | Methods of preparing a primary cell sample | |
EP3199665A4 (en) | Electrolytic cell for production of organic chemical hydrides | |
EP3140425A4 (en) | Methods of linearly amplifying whole genome of a single cell | |
EP3149476A4 (en) | Subcellular western blotting of single cells | |
PL3526313T3 (en) | Gasification process employing acid gas recycle | |
PL3119575T3 (en) | Process for making isolating strips | |
HK1251620A1 (en) | Methods for assesing the purity of a mesenchymal stem cells preparation | |
PL3140392T3 (en) | Production of heteromultimeric proteins using mammalian cells | |
IL261999A (en) | Cell culture process | |
GB201608060D0 (en) | Method of culturing T cells | |
EP3233814A4 (en) | Novel process for the preparation of ranolazine | |
EP3196304A4 (en) | Method for improved high secretory production of proteins | |
DK3443110T3 (en) | FERMENTATION PROCESS FOR THE PRODUCTION OF MALTOSYL-ISOMALTO-OLIGOSACCHARIDES (MIMO) | |
EP3365920A4 (en) | Method of bifacial cell fabrication | |
PT3362405T (en) | Process for the production of methanol | |
SG10202103545PA (en) | Early post-transfection isolation of cells (epic) for biologics production | |
IL257814B (en) | Method for the production of praziquantel | |
ZA201704196B (en) | Method for the production of praziquantel | |
SG11201705095VA (en) | Process for the manufacture of solar cells | |
EP3224595A4 (en) | Process control for increased robustness of genetic assays |